SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $19,316,000 | +10.6% | 1,756,129 | -1.5% | 0.09% | +8.8% |
| Q1 2017 | $17,472,000 | -15.7% | 1,782,739 | -7.1% | 0.08% | -20.8% |
| Q4 2016 | $20,729,000 | +1.9% | 1,919,172 | -3.3% | 0.10% | 0.0% |
| Q3 2016 | $20,344,000 | -21.5% | 1,985,022 | -0.0% | 0.10% | -24.1% |
| Q2 2016 | $25,932,000 | +18.5% | 1,985,419 | -0.2% | 0.13% | +20.9% |
| Q1 2016 | $21,880,000 | +21.5% | 1,989,125 | +1.6% | 0.11% | +17.0% |
| Q4 2015 | $18,010,000 | +40.7% | 1,957,530 | +6.2% | 0.09% | +34.3% |
| Q3 2015 | $12,798,000 | -32.8% | 1,844,028 | -4.9% | 0.07% | -23.9% |
| Q2 2015 | $19,040,000 | +7.8% | 1,938,828 | -2.8% | 0.09% | +12.2% |
| Q1 2015 | $17,664,000 | -0.4% | 1,993,659 | -1.5% | 0.08% | +3.8% |
| Q4 2014 | $17,739,000 | +29.3% | 2,024,954 | +1.7% | 0.08% | +19.7% |
| Q3 2014 | $13,721,000 | +111.9% | 1,991,710 | +61.8% | 0.07% | +112.9% |
| Q2 2014 | $6,476,000 | +43.0% | 1,231,135 | +23.7% | 0.03% | +29.2% |
| Q1 2014 | $4,529,000 | -26.2% | 995,106 | -18.3% | 0.02% | -29.4% |
| Q4 2013 | $6,135,000 | -10.3% | 1,217,820 | -9.7% | 0.03% | -22.7% |
| Q3 2013 | $6,839,000 | – | 1,348,838 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|